Bringing science and development together through news and analysis

  • Malaria: back in the spotlight

Shares
In any given year, nearly ten per cent of the world’s population will suffer from malaria — 500 million clinical cases — and more than 1 million will die as a result.

And things are getting worse, as malaria is undergoing a resurgence due to the emergence of drug-resistant parasite strains, insecticide resistance in mosquitoes, environmental changes and increased population.

A group of articles in this week’s Nature describe latest research developments, likely future progress and the practical impact that the new knowledge will have.

Reference: Nature 415, 669 (2002)

Malaria in 2002
The pathogenic basis of malaria
The economic and social burden of malaria
Medical need, scientific opportunity and the drive for antimalarial drugs
Progress and challenges for malaria vaccines
Plasmodium, human and Anopheles genomics and malaria
Satellite imagery in the study and forecast of malaria


Republish
We encourage you to republish this article online and in print, it’s free under our creative commons attribution license, but please follow some simple guidelines:
  1. You have to credit our authors.
  2. You have to credit SciDev.Net — where possible include our logo with a link back to the original article.
  3. You can simply run the first few lines of the article and then add: “Read the full article on SciDev.Net” containing a link back to the original article.
  4. If you want to also take images published in this story you will need to confirm with the original source if you're licensed to use them.
  5. The easiest way to get the article on your site is to embed the code below.
For more information view our media page and republishing guidelines.